(Q73833950)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

main subject

phase III clinical trial

1 reference

stem cell transplantation

inferred from title

1 reference

systemic lupus erythematosus

inferred from title

0 references

author name string

Burt RK

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Marmont A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Arnold R

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Heipe F

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Firestein GS

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Carrier E

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Hahn B

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Barr W

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Oyama Y

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Snowden J

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Kalunian K

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Traynor A

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

32 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

S49-51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12931242%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703943

7 November 2019

exact match

0 references

cites work

Prognosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

The prognosis of lupus nephritis in African-Americans: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Hematopoietic stem-cell transplantation for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Collection of hematopoietic stem cells from patients with autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Measurement of systemic lupus erythematosus activity in clinical research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Corticotropin and cortisone treatment for systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Recurrent acute lupus erythematosus disseminatus: report of a case which has survived 23 years after the onset of systemic manifestations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703943

7 January 2021